Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 16,599 | 9,545 | 7,139 | 7,471 | 9,510 |
| Cost of Goods | 8,680 | 7,500 | 5,550 | 6,260 | 7,510 |
| Gross Profit | 7,910 | 2,070 | 1,580 | 1,200 | 1,990 |
| Operating Expenses | 8,870 | 9,500 | 7,810 | 9,060 | 9,290 |
| Operating Income | -271 | -6,955 | -5,671 | -7,589 | -6,780 |
| Other Income | 2,151 | 5 | -879 | 12,129 | -4,670 |
| Pre-tax Income | 1,880 | -6,950 | -6,550 | 4,540 | -11,450 |
| Net Income Continuous | 1,886 | -6,947 | -6,554 | 4,540 | -11,451 |
| Net Income | $1,886 | $-6,947 | $-6,554 | $4,540 | $-11,451 |
| EPS Basic Total Ops | 700.00 | -2,900.00 | -3,500.00 | 2,399.52 | -6,598.68 |
| EPS Basic Continuous Ops | 754.40 | -2,894.58 | -3,449.47 | 2,389.47 | -6,361.67 |
| EPS Diluted Total Ops | 700.00 | -2,900.00 | -3,500.00 | 2,399.52 | -6,598.68 |
| EPS Diluted Continuous Ops | 754.40 | -2,894.58 | -3,449.47 | 2,389.47 | -6,361.67 |
| EBITDA(a) | $-11 | $-6,955 | $-5,671 | $-8,619 | $-5,180 |